TY

Teng Yue Partners

North America, New York, United States, New York

Description

New York based Teng Yue Partners, is one of the largest US asset management firms focusing on equity investments in China.

Investor Profile

Teng Yue Partners has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology.

Stage Focus

  • Post Ipo Equity (25%)
  • Series B (25%)
  • Series Unknown (25%)
  • Series C (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Teng Yue Partners frequently co-invest with?

Temasek Foundation
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 2
China Equity
Asia, Beijing, China, Beijing
Co-Investments: 1
CL
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
EC
North America, New Jersey, United States, North Bergen
Co-Investments: 1
China Merchants Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by Teng Yue Partners?

Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Post Ipo EquityNov 29, 2021
Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Series CDec 23, 2020
Amount Raised: $105,000,000
Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Series BJan 8, 2020
Amount Raised: $100,000,000
Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Series UnknownJan 2, 2019
Amount Raised: $137,000,000